SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

BREAKING BOUNDARIES OF SCIENCE, TECHNOLOGY, MEDICINE, ART & HEALTHCARE POLICY

Session Chair: Mojtaba Barzegar, MS

10:00 – 10:15 AM
Alzheimer’s biomarkers among diverse populations: The HABS-HD study

Sid O’Bryant, PhD

Executive Director, Institute for Translational Research Professor, TCOM Department of Family Medicine University of North Texas Health Science Center, USA

10:15 – 10:30 AM
The role of PET-MRI in Differential Diagnostic of Dementia

Mojtaba Barzegar, MS

CEO & Co-Founder of IQMBI, Head of MRI at the National Brain Mapping Lab, Iran

10:30 – 10:45 AM
The Issues of Genetic Testing and Alzheimer’s Risk

J. Wesson Ashford, MD, Ph.D.

Director at War Related Illness & Injury Study Center, VA Palo Alto Health Care System, Clinical Professor of Psychiatry and Behavioral Sciences Stanford University 14th President of SBMT, CA, USA

10:45 – 11:15 AM
The Impact of Disclosing Genetic Testing to the Patient

Jamie Tyrone, RN – Featured Speaker

CEO & Founder of Beating Alzheimer’s by Embracing Science

11:15 – 11:30 AM
Q & A

Session Chairs

March 16 @ 10:00
10:00 — 11:30 (1h 30′)

Room 409 B

Alzheimer’s Disease and Dementia

Add